The company's new GLP-1 program will offer both oral and injectable medications Courtesy Amazon Amazon has launched a new GLP ...

In December, Vanda Pharmaceuticals gained FDA approval for its motion sickness drug Nereus. But a much larger patient population may be in store for the oral therapy as the Washington, D.C.-based ...

(WHTM) — The snack industry feels the side effects as more people use GLP-1 weight-loss drugs. The Hershey Company listed GLP-1 as a headwind affecting chocolate sales, alongside economic stress and ...

Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

Matthew Herper covers medical innovation — both its promise and its perils. Specific changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs used to ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

SINCE 2000. THERE’S A NEW REPORT THAT’S OUT TONIGHT THAT FINDS THAT WOMEN ARE LOSING MORE WEIGHT WITH GLP ONES THAN MEN. SO HERE TO ANSWER THAT, JUST TO TALK ABOUT IT, DOCTOR TODD ELLEN FROM SOUTH ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...